Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to 0.34.

  • BridgeBio Pharma's Asset Utilization Ratio rose 1406.9% to 0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34, marking a year-over-year increase of 1406.9%. This contributed to the annual value of 0.3 for FY2024, which is 180307.9% up from last year.
  • Per BridgeBio Pharma's latest filing, its Asset Utilization Ratio stood at 0.34 for Q3 2025, which was up 1406.9% from 0.24 recorded in Q2 2025.
  • BridgeBio Pharma's Asset Utilization Ratio's 5-year high stood at 0.34 during Q3 2025, with a 5-year trough of 0.0 in Q1 2021.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.09 (2022), whereas its average is 0.13.
  • Per our database at Business Quant, BridgeBio Pharma's Asset Utilization Ratio plummeted by 11041.03% in 2021 and then soared by 255292.22% in 2024.
  • Quarter analysis of 5 years shows BridgeBio Pharma's Asset Utilization Ratio stood at 0.01 in 2021, then skyrocketed by 883.85% to 0.11 in 2022, then plummeted by 86.52% to 0.02 in 2023, then surged by 1708.76% to 0.28 in 2024, then increased by 21.53% to 0.34 in 2025.
  • Its Asset Utilization Ratio was 0.34 in Q3 2025, compared to 0.24 in Q2 2025 and 0.14 in Q1 2025.